Tag archive for ‘Achillion Pharmaceuticals’
Now That Pharmasset and Achillion Have Received Takeover Bids; Is Achillion Next? (ACHN, $9.72)
Following the announcement that Gilead was proposing to acquire Pharmasset (VRUS), I postulated in a note written on November 11, 2011 that Inhibitex (INHX) and Achillion (ACHN) were the next possible targets as big pharma companies seek to put together HCV drug assets. On January 13, Bristol-Myers announced that it proposed to acquire Inhibitex. I […]
Achillion Could Be On Big Pharma’s Acquisition List (ACHN, $6.00)
Gilead (GILD) is certainly paying up for Pharmasset with its offer to buy the company at $137 per share ($11 billion), an 89% premium to last Friday’s close. Gilead will be paying for the acquisition with cash on hand and debt. Relative to alternatives such as investing money in short term debt instruments or doing […]
Gilead Makes Bid for Pharmasset: Could Achillion Be Next in Big Pharma’s Acquisition Gun Sights (ACHN, $6.00)
Gilead (GILD) is certainly paying up for Pharmasset with its offer to buy the company at $137 per share ($11 billion), an 89% premium to last Friday’s close. Gilead will be paying for the acquisition with cash on hand and debt. Relative to alternatives such as investing money in short term debt instruments or doing […]